Literature DB >> 33201205

Bladder Cancer.

Andrew T Lenis1, Patrick M Lec1, Karim Chamie1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33201205     DOI: 10.1001/jama.2020.17601

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer.

Authors:  Jacqueline Wahura Waweru; Kennedy Wanjau Mwangi; Vayda R Barker; Etienne C Gozlan; Michelle Yeagley; George Blanck; Francis W Makokha
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-13       Impact factor: 4.322

2.  Prognosis Analysis and Perioperative Research of Elderly Patients with Non-Muscle-Invasive Bladder Cancer under Computed Tomography Image of Three-Dimensional Reconstruction Algorithm.

Authors:  Hongying Ke; Dandan Qiu; Zhicheng Cong
Journal:  Contrast Media Mol Imaging       Date:  2022-06-06       Impact factor: 3.009

3.  Preoperative White Blood Cell-Related Indicators Can Predict the Prognosis of Patients with Transurethral Resection of Bladder Cancer.

Authors:  Mingde Gao; Qiuxing Yang; Haifei Xu; Zhigang Chen; Xiaolin Wang; Haifeng Guo
Journal:  J Inflamm Res       Date:  2022-07-21

4.  Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients.

Authors:  Xin Huang; Hao-Fei Wang; Shuang Huang
Journal:  Front Genet       Date:  2022-08-17       Impact factor: 4.772

5.  Retrospective analysis of bladder cancer morphology and depth of invasion under cystoscopy.

Authors:  Hu Chen; Yang Hong; Bai Yu; Li Ruiqian; Li Jun; Wu Hongyi; Wang Ziyong; Jiang Haiyang; Zhang Chongjian; Bi Ying; Wang Qilin
Journal:  BMC Urol       Date:  2022-01-31       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.